Victoria will undergo brain surgery on Jan. 17 in Houston, but her problems won’t go away with just one operation.

Corcept Therapeutics Incorporated (NASDAQ: CORT) has recently submitted a New Drug Application (NDA) to the U.S. Food and ...

CORT makes pipeline progress with the submission of a new drug application for relacorilant to treat patients with endogenous hypercortisolism.

Corcept Therapeutics Inc. (CORT) said that it has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe e ...

Corcept Therapeutics submitted a new drug application to the Food and Drug Administration for its treatment of hypercortisolism, or Cushing's syndrome, a hormonal disorder that occurs when the body ...

DEAR JOAN: My daughter has a dog that has been suffering with Cushing’s disease for several years now. She cannot get up on ...

Asherman's syndrome is most often caused by uterine scarring following a dilation and curettage procedure (D&C), in which tissues from the uterus are removed. Cushing syndrome occurs when your body ...

In patients with Cushing’s syndrome, hypercortisolemia causes various complications, including cerebrocardiovascular events, infectious diseases, and thromboembolisms, which increase mortality (1–3).

Some patients with medullary thyroid cancers, pancreatic neuroendocrine tumors, and endogenous Cushing syndrome can also develop flushing. Nikolic M, Majdandzic M, Colonnesi C, de Vente W, Moller E, ...

LUBUMBASHI, Democratic Republic of the Congo – The nation's health ministry said Tuesday that a previously unidentified disease circulating in the country's Panzi health zone is a severe form ...

In addition to Cushing's syndrome, relacorilant is being investigated for its potential use in treating various cancers, including ovarian, adrenal and prostate cancer. Corcept holds proprietary ...